Illumina, Inc. filed a Form 8-K to announce the settlement and proposed dismissal of litigation captioned Icahn Partners LP, et al., v. Francis DeSouza, et al., arising from its approximately $8 billion acquisition of GRAIL, Inc. The parties entered into a Release Agreement on August 21, 2025, providing for mutual releases without any monetary payment by either side. The action will be dismissed with prejudice as to the plaintiffs only, while remaining without prejudice to other stockholders and three pending derivative actions. Defendants continue to deny all claims of wrongdoing or liability. A court hearing on the proposed dismissal is scheduled for November 2, 2026. Illumina, Inc. operates in the life sciences industry, specializing in DNA sequencing and analysis technologies.
